Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joey L Methot

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Bioorganic & Medicinal Chemistry Letters|September 1, 2007
The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitorsChristopher L Hamblett, Joey L Methot, Dawn M Mampreian, et al.
Journal of Medicinal Chemistry|April 16, 2019
Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved TolerabilityJoey L Methot, Hua Zhou, Sam D Kattar, et al.
Nature Communications|January 3, 2026
WRN structural flexibility showcased through fragment-based lead discovery of inhibitorsRachel L Palte, Mihir Mandal, Justyna Sikorska, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2008
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)Joey L Methot, Prasun K Chakravarty, Melissa Chenard, et al.
Journal of Medicinal Chemistry|April 2, 2021
Projected Dose Optimization of Amino- and Hydroxypyrrolidine Purine PI3Kδ ImmunomodulatorsJoey L Methot, Hua Zhou, Meredeth A McGowan, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2015
Discovery of novel triazolobenzazepinones as γ-secretase modulators with central Aβ42 lowering in rodents and rhesus monkeysChristian Fischer, Susan L Zultanski, Hua Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2015
Potent benzoazepinone γ-secretase modulators with improved bioavailabilityJoey L Methot, Christian Fischer, Chaomin Li, et al.
RSC Medicinal Chemistry|August 6, 2021
Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitorsAnmol Gulati, Charles S Yeung, Blair Lapointe, et al.
Journal of Medicinal Chemistry|December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's DiseaseDavid A Candito, Vladimir Simov, Anmol Gulati, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Bioorganic & Medicinal Chemistry Letters|September 1, 2007
The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitorsChristopher L Hamblett, Joey L Methot, Dawn M Mampreian, et al.
Journal of Medicinal Chemistry|April 16, 2019
Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved TolerabilityJoey L Methot, Hua Zhou, Sam D Kattar, et al.
Nature Communications|January 3, 2026
WRN structural flexibility showcased through fragment-based lead discovery of inhibitorsRachel L Palte, Mihir Mandal, Justyna Sikorska, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2008
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)Joey L Methot, Prasun K Chakravarty, Melissa Chenard, et al.
Journal of Medicinal Chemistry|April 2, 2021
Projected Dose Optimization of Amino- and Hydroxypyrrolidine Purine PI3Kδ ImmunomodulatorsJoey L Methot, Hua Zhou, Meredeth A McGowan, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2015
Discovery of novel triazolobenzazepinones as γ-secretase modulators with central Aβ42 lowering in rodents and rhesus monkeysChristian Fischer, Susan L Zultanski, Hua Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2015
Potent benzoazepinone γ-secretase modulators with improved bioavailabilityJoey L Methot, Christian Fischer, Chaomin Li, et al.
RSC Medicinal Chemistry|August 6, 2021
Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitorsAnmol Gulati, Charles S Yeung, Blair Lapointe, et al.
Journal of Medicinal Chemistry|December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's DiseaseDavid A Candito, Vladimir Simov, Anmol Gulati, et al.
Pageof 3